title: Intriguing structure-activity relations underlie the potent inhibition of HIV protease by norstatine-based peptides.
authors.affiliation: Syntex Research Canada, Mississauga, Ontario.
authors.forename: T F
authors.initials: TF
authors.lastname: Tam
authors.forename: J
authors.initials: J
authors.lastname: Carrière
authors.forename: D
authors.initials: D
authors.lastname: MacDonald
authors.forename: A L
authors.initials: AL
authors.lastname: Castelhano
authors.forename: D H
authors.initials: DH
authors.lastname: Pliura
authors.forename: N J
authors.initials: NJ
authors.lastname: Dewdney
authors.forename: E M
authors.initials: EM
authors.lastname: Thomas
authors.forename: C
authors.initials: C
authors.lastname: Bach
authors.forename: J
authors.initials: J
authors.lastname: Barnett
authors.forename: H
authors.initials: H
authors.lastname: Chan
mesh_terms: D000614:Aminocaproates / Q000737:chemistry* / Q000494:pharmacology; D017320:HIV Protease Inhibitors; D015497:HIV-1 / Q000201:enzymology*; D015394:Molecular Structure; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology*; D011487:Protein Conformation; D013329:Structure-Activity Relationship
chemical_list: D000614:Aminocaproates; D017320:HIV Protease Inhibitors; D010455:Peptides; C034495:3-amino-2-hydroxy-5-methylhexanoic acid